Abstract
To better assist primary healthcare providers in recognizing the importance of postnatal bilirubin monitoring, and in developing the ability to promptly identify neonatal jaundice that requires intervention and to provide appropriate evaluation and management, thereby reducing severe neonatal hyperbilirubinemia requiring exchange transfusion and bilirubin encephalopathy while avoiding overtreatment, the Subspecialty Group of Neonatology, Society of Pediatrics, Chinese Medical Association and the Editorial Board of Chinese Journal of Contemporary Pediatrics organized experts who, based on the national expert consensus and guidelines on neonatal hyperbilirubinemia, integrated the latest clinical research evidence on neonatal jaundice and, after thorough discussion, formulated the "Guidelines for the diagnosis and treatment of common neonatal diseases in primary healthcare institutions: neonatal jaundice (2025)". The guideline addresses 10 common clinical questions on neonatal jaundice for primary healthcare providers and provides 16 recommendations.